GEHC Shares Rally 2.17% on Strategic Updates as Trading Volume Surges 38.12% to $230M Ranking 485th in Market Activity

On September 5, 2025, , ranking 485th in market activity. The stock's performance was driven by strategic updates and operational resilience highlighted during the Wells Fargo Healthcare Conference.

The company announced a 50-basis-point upward revision to its full-year guidance midpoint, . Key initiatives include launching Flurcado and Photon Counting CT technologies, . , management projected stabilization in 2026, .

Market challenges in China, including extended tender processes, were acknowledged, though the company expressed cautious optimism about recovery. Digital revenue growth remains a focal point, . Strategic priorities include M&A activity and innovation in connected healthcare platforms to sustain long-term growth.

To run this back-test accurately I need a few extra details: 1. Universe – Which market should the 500-stock selection be drawn from (e.g., all U.S. common stocks on NYSE + NASDAQ, or another universe)? 2. Entry/exit prices – Should the trade be: • buy at today’s close, sell at tomorrow’s close, or • buy at tomorrow’s open, sell at tomorrow’s close, etc.? 3. Weighting – Equal-weight all 500 names, or weight by something else (e.g., proportional to their dollar volume)? Once we lock these points in I can set the parameters and launch the back-test.